This invention relates to the use of potent potassium channel blockers or a
formulation thereof in the treatment of glaucoma and other conditions which leads
to elevated intraoccular pressure in the eye of a patient. This invention also
relates to the use of such compounds to provide a neuroprotective effect to the
eye of mammalian species, particularly humans.
